中华实验外科杂志
中華實驗外科雜誌
중화실험외과잡지
CHINESE JOURNAL OF EXPERIMENTAL SURGERY
2011年
3期
449-451
,共3页
徐峰%阮国锋%郑浩%郑小青%詹鸣%李怀富
徐峰%阮國鋒%鄭浩%鄭小青%詹鳴%李懷富
서봉%원국봉%정호%정소청%첨명%리부부
超抗原%葡萄球菌肠毒素A%血清白蛋白%纳米粒%基因载体
超抗原%葡萄毬菌腸毒素A%血清白蛋白%納米粒%基因載體
초항원%포도구균장독소A%혈청백단백%납미립%기인재체
Superantigen%Staphylococcal enterotoxin A%Serum albumin%Nanoparticles%Gene vector
目的 构建一种非病毒载体基因投递系统-携带超抗原葡萄球菌肠毒素A(SEA)基因的白蛋白纳米载体,观察白蛋白纳米粒表征并探讨其潜在的靶向基因投递作用和强大的抗瘤机制.方法 采用去溶剂化法制备白蛋白纳米粒,平均粒径(253.1±11.9)nm,Zeta电位(-34.0±4.5)mV,PDI 0.43±0.04;抽提SEA基因质粒(pSEA)260/280:1.84±0.02,pSEA浓度:(85.54±1.43)mg/L;经生物活性及基因测序鉴定后耦合SEA基因质粒和白蛋白纳米载体,并观察耦合物的稳定性及白蛋白纳米载体对SEA基因的保护作用.结果 成功构建携带超抗原SFA基因的白蛋白纳米载体,平均粒径(118.9±4.8)nm,Zeta电位(-43.9±10.5)mV,PDI 0.19±0.02,基因转载率为(97.61±0.06)%,性质稳定、分散性较好,体外实验表明白蛋白纳米载体能保护SEA基因免受DNase Ⅰ的降解.结论 获得符合超抗原SEA基因转染要求的白蛋白纳米载体.
目的 構建一種非病毒載體基因投遞繫統-攜帶超抗原葡萄毬菌腸毒素A(SEA)基因的白蛋白納米載體,觀察白蛋白納米粒錶徵併探討其潛在的靶嚮基因投遞作用和彊大的抗瘤機製.方法 採用去溶劑化法製備白蛋白納米粒,平均粒徑(253.1±11.9)nm,Zeta電位(-34.0±4.5)mV,PDI 0.43±0.04;抽提SEA基因質粒(pSEA)260/280:1.84±0.02,pSEA濃度:(85.54±1.43)mg/L;經生物活性及基因測序鑒定後耦閤SEA基因質粒和白蛋白納米載體,併觀察耦閤物的穩定性及白蛋白納米載體對SEA基因的保護作用.結果 成功構建攜帶超抗原SFA基因的白蛋白納米載體,平均粒徑(118.9±4.8)nm,Zeta電位(-43.9±10.5)mV,PDI 0.19±0.02,基因轉載率為(97.61±0.06)%,性質穩定、分散性較好,體外實驗錶明白蛋白納米載體能保護SEA基因免受DNase Ⅰ的降解.結論 穫得符閤超抗原SEA基因轉染要求的白蛋白納米載體.
목적 구건일충비병독재체기인투체계통-휴대초항원포도구균장독소A(SEA)기인적백단백납미재체,관찰백단백납미립표정병탐토기잠재적파향기인투체작용화강대적항류궤제.방법 채용거용제화법제비백단백납미립,평균립경(253.1±11.9)nm,Zeta전위(-34.0±4.5)mV,PDI 0.43±0.04;추제SEA기인질립(pSEA)260/280:1.84±0.02,pSEA농도:(85.54±1.43)mg/L;경생물활성급기인측서감정후우합SEA기인질립화백단백납미재체,병관찰우합물적은정성급백단백납미재체대SEA기인적보호작용.결과 성공구건휴대초항원SFA기인적백단백납미재체,평균립경(118.9±4.8)nm,Zeta전위(-43.9±10.5)mV,PDI 0.19±0.02,기인전재솔위(97.61±0.06)%,성질은정、분산성교호,체외실험표명백단백납미재체능보호SEA기인면수DNase Ⅰ적강해.결론 획득부합초항원SEA기인전염요구적백단백납미재체.
Objective To assess the characteristics of human serum albumin nanoparticles (HSA-NP) as a nonviral vector system for delivery staphylococcal enterotoxin A (SEA) gene and probe into its potential targeted antitumor mechanism.Methods HSA-NP and plasmid containing SEA gene (pSEA)encapsulated in HSA (pSEA-HSA-NP) were prepared by a desolvation-crosslinking method.HSA-NP had a mean size of (253.1 ± 11.9) nm,zeta potential of ( -34.0 ±4.5) mV,polydispersity index of 0.43 ±0.04.The superantigen SEA gene was extracted by the Endo-Free Plasmid Maxi Kit,260/280 of pSEA was 1.84 ±0.02 and the concentration of pSEA was ( 85.54 ± 1.43 ) mg/L.pSEA was verified by sequencing and biological activity survey,the stability of pSEA-HSA-NP was investigated by laying for 10 days at room temperature,and the size and zeta potential were remeasured and contrasted with the samples 10 days before.HSA-NP protecting pSEA from degradation of DNase I was detected by gel electrophoresis.Results Electrophoretic mobility analysis and fluorescent labeling revealed that pSEA-HSA-NP was successfully constructed.PSEA-HSA-NP had a mean size of ( 118.9 ±4.8) nm,zeta potential of ( -43.9 ± 10.5 ) mV,polydispersity index of 0.19 ±0.02 and pSEA encapsulation efficiency of (97.61 ±0.06)%.The characteristics of pSEA-HSA-NP solution laying for 10 days at room temperature indicated a better stability and polydispersity.HSA-NP stabilizing pSEA against DNase I in vitro was also testified by gel electrophoresis.Conclusion pPSEA-HSA-NP served the transfecting needs of superantigen SEA gene.